Data Foundry

Drug recalls 2013

Piperacillin and Tazobactam for Injection — Class I drug recall D-835-2013

Terminated recall by Apotex Corp., reported 2013-08-14, distributed nationwide. Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.

Recall numberD-835-2013
Product typeDrug
ClassificationClass I
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmApotex Corp., Weston, FL, United States
Recall initiated2013-05-10
Classified2013-08-02
Reported by FDA2013-08-14
Terminated2018-01-08
DistributedNationwide (US)
Quantity52,398 vials
NDC60505-0773-00
Lot numbers01/14, 02/14, 04/14, 08/13, 11/13, 12/13, 503B023, 503B028, 503B029, 503B030, 503B031, 503B032, 503B033, 503C001, 503C002, 503C003, 503C004, 503C009, 503C010, 503C011, 503C012, 503C014, 503C015, 503C016, 503C017, 503C019, 503C020

Product

Piperacillin and Tazobactam for Injection, USP, 40.5 grams per Pharmacy Bulk Package vial, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd., Irungattukottai - 602 105, India; Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0773-0

Reason for recall

Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-835-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.